日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug

针对被忽视的疾病的药物配方。NANOHAT 项目旨在开发更安全、更有效的昏睡病药物

Lisa Sanderson, Marcelo da Silva, Gayathri N Sekhar, Rachel C Brown, Hollie Burrell-Saward, Mehmet Fidanboylu, Bo Liu, Lea Ann Dailey, Cécile A Dreiss, Chris Lorenz, Mark Christie, Shanta J Persaud, Vanessa Yardley, Simon L Croft, Margarita Valero, Sarah A Thomas

Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana In Vitro

壳聚糖及其衍生物体外抗利什曼原虫和墨西哥利什曼原虫的活性

Alaa Riezk, John G Raynes, Vanessa Yardley, Sudaxshina Murdan, Simon L Croft

An efficient and novel technology for the extraction of parasite genomic DNA from whole blood or culture

一种从全血或培养物中提取寄生虫基因组 DNA 的高效新技术

David J Clark, Catherine M Moore, Marc Flanagan, Katrien Van Bocxlaer, Evangelia-Theophano Piperaki, Vanessa Yardley, Simon L Croft, John Tyson, Sam P Whitehouse, Jonathan O'Halloran, Sanjeev Krishna, Henry M Staines

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

具有抗实验性皮肤利什曼病活性的新型苯并氧硼酸、硝基咪唑和氨基吡唑

Katrien Van Bocxlaer, Diana Caridha, Chad Black, Brian Vesely, Susan Leed, Richard J Sciotti, Gert-Jan Wijnant, Vanessa Yardley, Stéphanie Braillard, Charles E Mowbray, Jean-Robert Ioset, Simon L Croft

Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis

硝基咪唑 DNDI-0690 在皮肤利什曼病小鼠模型中的药代动力学和药效学

Gert-Jan Wijnant, Simon L Croft, Raul de la Flor, Mo Alavijeh, Vanessa Yardley, Stéphanie Braillard, Charles Mowbray, Katrien Van Bocxlaer

Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis

实验性内脏利什曼病模型中的组织和宿主物种特异性转录变化

Helen Ashwin, Karin Seifert, Sarah Forrester, Najmeeyah Brown, Sandy MacDonald, Sally James, Dimitris Lagos, Jon Timmis, Jeremy C Mottram, Simon L Croft, Paul M Kaye

In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial

喹诺里西啶修饰的 4-氨基喹啉的体内和体外活性以及 ADME-Tox 特性:一种有效的抗恶性疟原虫和抗间日疟原虫血液阶段抗疟药

Nicoletta Basilico, Silvia Parapini, Anna Sparatore, Sergio Romeo, Paola Misiano, Livia Vivas, Vanessa Yardley, Simon L Croft, Annette Habluetzel, Leonardo Lucantoni, Laurent Renia, Bruce Russell, Rossarin Suwanarusk, Francois Nosten, Giulio Dondio, Chiara Bigogno, Daniela Jabes, Donatella Taramelli